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1. Introduction 
Overt thyroid disease often involves mood disorders and cognitive impairment in adults. 
But at the subclinical level a relationship has been difficult to establish.  Some authors 
regard thyroid stimulant hormone small elevation in the elderly as part of aging. However, 
there is a body of studies that demonstrate the impact of SH in target tissues; vg, ejection 
fraction and lipid profile alterations; thus many experts recommend comprehensive 
treatment, adjusting it to the patient´s specific context, age, comorbidities etc. However, 
regarding cognitive and mood problems there is still controversy. There are studies 
concluding no association between SH, cognition or depression but these used insensitive 
instruments to measure cognition and depression, or they had some other methodological 
bias. There are also cross-sectional and case studies showing an association with newly-
developed more sensitive instruments. Subclinical hypothyroidism, cognitive impairment 
and depression occur more often in old age. Population aging increases SH, cognitive 
impairment, and depression prevalence and this will be a health burthen for patients, their 
families, and society; thus measures to minimize it is urgent in developing countries, where 
a high increase in the elderly population is expected. Indeed Heathcare polices everywhere 
must strive for mind and physical well-being. We will review instruments to screen and 
score different spheres of cognitive function in the geriatric or general practitioner´s office, 
and assess the available evidence, and aspects that need further investigation.  
2. Definitions  
1. Subclinical hypothyroidism (SH) is defined as an elevated serum thyroid stimulant 
hormone (TSH) level  4.0 mUI/L with free thyroxine (FT4) within normal range, with 
or without symptoms. 
2. Cognition impairment: refers to decrease ability in mental activities to acquire, store, 
retrieve and use information. People with mild cognitive impairment are able to 
perform basic everyday activities, but present mental decline (forgetfulness, confusion, 
inattention etc) noticeable by themselves, their relatives, or test. While in dementia the 
performing of everyday activities are also deteriorated. 
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3. Depression is a long lasting sadness accompanied by loss of interest in activities; even 
activities the subject finds enjoyable. It can affect mental activity, behavior, and general 
well-being. 
3. Subclinical hypothyroidism 
3.1 Prevalence and risk factors for SH 
 SH comprises the largest fraction of TSH elevation. SH predominates in women, and its 
prevalence increases with age. In the United States, the percent of individuals with TSH over 
4.5 mIU/L raises to 14% after 70 years of age [Hollowell et al 2002]. But a study [Hoogendoorn 
et al 2006] in Netherlands reported 4.4% of adult population with TSH over 4.0 mU/L; it also 
reported a decrease in the mean TSH by age (Figure 1). In Spain, a study reported a prevalence 
of hypothyroidism (TSH >6.7 mUI/L) of 11% in 60-69 age group population [Sender Palacios 
et al, 2004]. In Cuba, [Hernandez-Perera et al 2005] reported that 5.3% of population older than 
59 years had a serum TSH >5.6 mU/L. The prevalence estimates have varied depending on the 
population studied and the criteria used to define it. 
 
Fig. 1. TSH IU/L by Age Adapted from Hoogendoorn et al 2006 
Besides age and gender, genetics is among the population factors that inflict variation to 
prevalence estimates, accounting for almost 65% thyroidal phenotype [Samollow et al 2004, 
Peeters RP 2009]. Also, the amount of dietary iodine has to be considered. Its deficiency 
translates into endemic goiter, congenital hypothyroidism and other thyroidal dysfunction 
[Jameson & Weetman, 2005]. Sustained implementation of iodinated salt has been successful in 
abating simple goiter and cretinism [Basil S Hetzel 2004]. In Mexico City, Martinez et al [1999] 
reported 11% of subjects 55 and older with TSH higher than 5.6 IU/L; however, in Monterrey 
Mexico, a region formally known for endemic goiter, 27.3% of geriatric outpatients had TSH 
>4.5 IU/L [Cárdenas-Ibarra et al 2008]. The unexpectedly high frequency was confirmed by a 
population study [Cárdenas-Ibarra et al 2011a]. Another interesting observation of this study 
was a non significant difference of prevalence by gender, suggesting that advancing age 
decreases the gender gap of SH prevalence. The inhabitants of this region tend to ingest rather 
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large quantities of iodinated salt (the only one available for a half century now) owing to the 
very hot weather that characterized this region. According with iodine sufficiency is the region 
low goiter prevalence (Cárdenas-Ibarra et al 2011a) and that 93.4% of congenital 
hypothyroidism is due to thyroid dysgenesis  and 6% dyshormogenesis (Vela-Amieva et al 
2003). Albeit, urinary iodine excretion was not measured. NHANES III [Hollowell et al 2002] 
reported an increase in mean TSH with age (see Figure 2) and also  significantly higher TSH 
concentrations in persons with high iodine excretion (>500 g/g creatinine) than in persons 
with normal iodine excretion (50–500 g/g creatinine) (P < .02). Moreover, in a borderline 
sufficient iodine intake prevalence of overt hypothyroidism was 0.4% and subclinical 4.0%. In 
this study decreasing TSH serum levels with age were also observed [Hoogendoorn et al 2006] 
(Fig 1). Thyroid malfunction may come from an excess of iodine intake by a direct inhibitory 
effect to the thyroidal gland or by eliciting autoimmunity [Teng et al 2006]. Impairment in 
thyroid function changes directly with thyroid autoimmunity; but high urinary iodine 
excretion predicted an increase of TSH and antithyroperoxidase antibodies one month later 
[Karmisholt & Laurberg 2008]. Surveillance of dietary iodine is recommended. 
 
Fig. 2. TSH IU/L by Age Adapted from Hollowell et al 2002 
3.2 Clinical aspects of SH in the old 
Thyroxine regulates the metabolism of all cells, rendering multisystem unspecific symptoms. 
Diagnosis of hypothyroidism in the elderly is specially challenging, since it develops very 
insidiously and symptoms usually go unnoticed [VermaA & Hasan 2009]. Even when 
symptoms are noted, they are confused with other health problems or are disregarded because 
they are thought to be part of aging. A questionnaire assessing hypothyroidism somatic 
symptoms was not able to predict abnormal TSH levels [Cárdenas-Ibarra et al 2011a]. See 
Table 1. In general, in symptom comparison among groups [Canaris et al 2004], subclinical 
hypothyroidism versus euthyroidism can show significant differences. These researchers 
reported a positive but weak association between the proportion of symptoms reported by the 
patients and progression of thyroid failure. Single or grouped symptoms are of little value at 
the individual level in just one consultation; thus most often SH is regarded as asymptomatic. 
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It is not until the patient is on levothyroxine that he/she notices improvement, such as less 
body aches, and not running out of energy. However, other symptoms such as weight change, 
puffy eyes, or hoarse voice take longer too reverse, if they do. Other functions such as 
cognition and mood symptoms can be reliably measured through validated instruments, but 
memory and depression complaints can not discriminate SH from euthyroidism. Mental 
slowing and depression are among the early hypothyroidism symptoms. Screening thyroid 
function in the elderly can save a lot of time, permit the implementation of appropriate 
measures, and avoid anguish to the patients and their families.  
 
Symptom Sensitivity Especificity 
Doesn’t sweat 0.28 0.76 
Deep voice 0.31 0.70 
Paresthesia 0.64 0.47 
Dry skin 0.56 0.59 
Constipation 0.51 0.65 
Can’t lose weight 0.49 0.76 
Slow to move 0.36 0.76 
Rough skin 0.35 0.74 
Puffy eyes 0.47 0.78 
Cold intolerance 0.31 0.78 
Cárdenas-Ibarra et al 2011a 
Table 1. Symptoms on subjects with and without SH 
3.3 Brain and thyroidal hormones 
The availability of active thyroid hormone in adult brain results from the balance of its 
activation and inactivation [Kester et al 2004]. The selenoenzyme, type 2 iodothyronine 
deiodinase, removes an outer ring iodine atom from the thyroxine to generate 
thriiodothyronine, the active hormone. The type 3 iodothyronine deiodinase removes an 
iner ring iodine to inactivate the hormone. Brain protection from thriiodothyronine swings 
is attained by coordinating the expression of type 2 and 3 deiodinases.  This is, expression of 
type 2 increases while type 3 decreases in low thyroxine; the opposite occurs with excess 
thyroxine. The monocarboxylate transporter-8 is a thyroid hormone specific transporter 
protein that crosses the blood-brain barrier. It is expressed in all brain locations involved in 
negative thyrotrophic releasing hormone feedback.  
The hypothalamus-pituitary-thyroid axis is controlled by thyroid receptor beta 2 isoform, 
which is expressed solely in the hypothalamus and anterior pituitary, and is specific for 
thriiodothyronine [Abel et al 1999]. Low level of hypothalamic triiodothyronine elevates 
TSH. Thyroid hormone receptor studies on mutant mice report that the behavior of mice, 
lacking receptor beta, brings to mind the attention-deficit-hyperactivity disorder. The mice 
lacking TR alpha respond poorly to fear conditioning, showing poor memory, high anxiety, 
and inhibition of exploratory behavior. [Williams 2008] 
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Triiodothyronine deficiency prevents proper glucose uptake in neurons and decreases brain 
perfusion impairing processes of cognition and mood [Kinuya et al 1999].  Functional 
Magnetic resonance imaging revealed load effect of blood oxygen level dependent on the 
response in regions of interest in the frontal cortex (working memory), absent  in subjects with 
SH, but present after six months of levothyroxine and improved performance in n-back task 
[Zhu et al 2006]. Hage &Azar 2011 review concluded that thyroid hormone supplements 
might help in the clinical response to antidepressive drugs.  It seems sensible to screen for 
thyroidal problems in patients with depression that do not respond to treatment.    
3.4 Normal thyroidal aging changes 
Morphologic changes are reduction of follicle and colloidal content; but the individual 
remains clinical healthy. In iodine plentiful regions, age and thyroid stimulant hormone are 
positively related, while free thyroxine does not show a significant change with age. Anti-
thyroeroxidase antibodies increase with age 8.5% in the 20-29 year age group to 22.3% in the 
70-79 year age group; but antibodies are related to disease rather than senescence. 
[Hollowell et al 2002]. In borderline sufficient iodine, THS decreases while free thyroxine 
increases with age and antithyroperoxidase antibodies show insignificant changes. Atzmon 
et al [2009] reported that remarkably old individuals had high serum TSH levels, and that 
their offspring also had higher TSH values than age-matched controls, but this might not be 
extrapolable to other populations.  
There is decreased production and release of TSH which produces 25% less production of 
thyroxine, but the serum level of thyroxine does not decrease due to underactive peripheral 
diiodinase type 2 function; also, the level of rT3 is positively age-related [Marioti et al 1993]. 
Hence the level of free Triiodothyronine decreases, but free thyroxine remains unchanged 
[Latrofa & Pinchera 2005]. There is no data of hypothalamic Triiodothyronine turnover to 
mantain adequate glucose uptake and brain perfusion in old age. 
4. Cognition 
Cognition comes from the Latin word cognoscere, meaning “to know”. Cognition refers to 
mental activities to acquire, store, retrieve and use information. The mental processes most 
tested to evaluate cognition decline are: orientation (time, place, person), memory (code and 
retrieval), visuospatial (perception and memory), attention (speed and discrimination), 
language (denomination, fluency, comprehension, read &  write), and executive function 
(concept, association, praxis) [Albert et al 1988].  
4.1 Instruments to measure cognition and mood 
The screening instruments most used to measure one or more of the above cognitive 
processes in general or geriatric clinical settings are: 
 Mood: “Geriatric Depression Scale” (GDS) Yesavage validated for screening; it is 
widely use in English and Spanish-speaking population [Yesavage 1986]. The Hospital 
Anxiety and Depression Scale (HADS) is a self-assessment scale for English speaking 
educated outpatients. [Zigmond & Snaith 1983]; Beck Depression Inventory is a self -
administrated 21 close-ended questionnaire [Beck 1961 in  Jorde et al 2006]. 
www.intechopen.com
 
Hypothyroidism – Influences and Treatments 
 
340 
 Mini-Mental-State-Examination (MMSE); low sensitivity in mild cognitive impairment; 
low specificity in subjects with less than middle schooling [Crum et al 1993].  
  Katz’s “Activities of daily-living” (Katz) useful for detecting dependence [Katz et al 
1970].  
 Lawton’s “Instrumental activities of daily-living” (LW) tests subject’s functionality. It 
has been used to screen for dementia [Lawton et al 1969]. 
 Dementia Rating Scale (DRS). Its application requires specialized personnel [APA 1994]. 
 Brief Neuropsychological Batteries; best options for screening (a paramedic can be 
trained to apply them): 
 ADAS-COG, (Alzheimer's Disease Assessment Scale-Cognitive) developed in 
educated Anglo population. Assesses orientation, memory, language, praxis, and 
executive function [Kolibas E et al 2000]. 
 NEUROPSI: it assesses orientation, attention, memory: coding (verbal and 
visuospacial) dilayed memory (verbal and visuoespacial), language, and executive 
function. It was validated and standardized in Latin-American population; it is also 
useful in illiterate subjects [Ostrosky et al 1999].   
 Evaluation of just one mental process saves times but the partial information can be 
misleading and many still need specialized personnel to apply it. [Begin et al 2008] For 
attention: paced auditory serial addition task, Stroop test, concept shifting, digit spans 
backward; for memory: Wechsler memory scale, facial memory test, selective reminding 
test, word learning task. Praxis clock drawing, Rey_Osterrieth complex figure, etc. 
4.2 Cognitive function in elderly 
Advancing age is the first risk factor for dementia, although dementia is not part of 
normal aging. There is a cognitive continuum disease that can be differentiated from 
normal although mild cognitive impaiment overlaps with both normal and disease 
[Petersen 2004]. Mood disorders are also overrepresented in the elderly, mainly 
depression: a long lasting feeling of sadness, hopeless, helpless, worthless, and aversion. 
Depression can affect mental activity, behavior and physical well-being. Cognitive 
function is affected by depression through interference in attention, memory (coding and 
retrieval), and decision taking.  
In absence of overt disease, a decline of cognitive performance is seen in aging. The decline 
is associated to brain age changes: less glucose utilization, long-term potentiation and 
paired-pulse facilitation, protein expression, neurotransmitter levels and trophic changes.  
But it is not known if the above changes produce or are a product of alterations in the old 
brain. Freeman et al 2009 in a proteomic study in an animal model demostrated that changes 
in hippocampal proteom were related to cognitive performance. They also indicated the 
relevance of comparing old subjects sub grouped by cognitive level; they found that 9 
hippocampal proteins were related with cognitive status. Only one was detected when 
comparing old with young animals. 
A study [Cárdenas-Ibarra et al 2006] in a randomly selected sample of 142 geriatric 
outpatients to determine the frequency of impaired cognition by Mini-mental test 
examination found that 74.5% of subjects did not completed basic schooling, thus MMSE 
scores above 20 instead of 26 were considered normal. Still, impaired cognition was found in 
59% vs 20% of those with partial vs full basic schooling (X2=4.52, gl=1,p<0.05). The 
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proportion of subjects with normal cognition decreased by age; in the over 80 y/o than in 
the 60-69 y/o, 27.3% vs 66.6% respectively (X2=15.3, gl=6,p<0.05). Disadvantaged scores for 
GDS and LW were among CI and dementia (p<0.05, ANOVA); and Katz only to dementia 
(p<0.05, ANOVA) concluded that 31.7% were known dementia cases; another 24% had a 
new diagnosis of impaired cognition. 
Ostrosky et al [Ardila et al 2000] used NEUROPSI in elderly urban population to describe 
normal cognitive decline in relation to education. They measured cognition in 806 subjects, 
of these 56.8% were over 50 years old. They reported different relationship patterns among 
education and specific cognitive domain; for example parallelism for copying a figure task, 
protection for word recall, confluence upwards for digits backwards, confluence 
downwards for semantic verbal fluency. they also found that healthy illiterate subjects 
showed no significant age decline in the domains of orientation, digits backward, language 
(repetition, naming, comprehension), and motor functions (hand position imitation, and 
alternating movement). Age changes are affected by education. Among the illiterate, peak 
performance is reached at an older age than subjects with formal education. Performance by 
age group and schooling on orientation, attention, coding, language motor function and 
memory subscales are shown in figure 3.  
 
                          
Fig. 3. Mean scores of Six Mental Processes by Age and Schooling 
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In agreement with cognitive preservation notion, a study in open elderly rural population 
found that about 12% of the subjects scored higher than normal ranges for age and 
schooling supplied in the NEUROPSI manual (Figure 4), confirming that lucidity can be 
present in advancing age with little or no formal education [Cárdenas-Ibarra et al 2011]. 
 
 
Fig. 4. Distribution of Rural Eldery's Neuropsi Score 
5. Thyroidal status and cognitive function 
Elderly people have the highest risk for thyroidal dysfunction as well as cognitive and mood 
disorders. Depression and memory complaints are excessively often in old age. In fact, 
depression is among the early symptoms of hypothyroidism; and memory loss relates to the 
level and length of thyroidal deficiency. Overall intellect is irreversibly affected in the 
developing brain as seen in congenital hypothyroidism. 
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The importance of thyroxine in the developing brain is well documented; the inability to 
focus and mood disturbances in the hyperthyroidal sate. Also in overt hypothyroidism lack 
of concentration, slow thinking and depression are described. In fact, it has been identified 
among the reversible causes of dementia [Jamerson & Weetman 2005]. But, Roberts et al 
[Roberts et al 2006] did not find association; neither did Gussekloo et al [Gussekloo et al 
2004]] in a cohort of aging subjects. But the cognitive assessment instrument they used was 
the Mini-Mental-State-Examination, which is not sensible for mildly impaired cognitive 
function; including LW and Katz in the cognitive assessment did not increase sensitivity for 
dysfunction not reaching dementia. However, Gussekloo et al also reported that low free T3 
was associated with rapid cognitive decline. These conflicting results demand studies with 
adequate assessments and well defined study groups.  
A cross-sectional study [Cárdenas-Ibarra et al 2008] was set to compare the frequency of 
thyroid stimulating hormone (TSH) >4.5 mUI/L level in 33 randomly selected geriatric 
outpatients without dementia versus 101 dementia cases (DSM-IV-R). High TSH was found 
in nine (27.3%, CI: 12.1- 42.5%) and thirty (29.7%, CI: 20.8-38.6%), respectively. It is worth 
mentioning that 76.7% were subclinical hypothyroidism; i.e., free thyroxin was in normal 
range. However, average free thyroxine levels in patients with a high TSH were significantly 
lower than those with a normal TSH; the  free thyroxine level of most of the subclinical 
hypothyroidism cases were in the lower half in contrast with the Gaussian distribution of 
free thyroxine in those with TSH in normal range. McDermott et al [McDermott & Ridway 
2001] conclude that many of subclinical hypothyroidism cases require treatment. Monzani et 
al [Monzani et al 1993] and Lauberg et al [Laurberg et al 2005] point out that in the presence 
of depression and/or cognitive decline, thyroid supplementation will improve symptoms. 
From the perspective of quality of life and patient care; even a modest cognitive 
improvement is highly desirable [Steverson 1990]. 
Treatment is only being recommended for patients with low range thyroxin levels; while the 
presence of cognitive decline, not reaching level of dementia, in subclinical hypothyroidism 
must be addressed in other studies to assess it potential benefit.  
To circumvent MMSE sensibility, specificity, language and cultural bias, we turn to 
NEUROPSI, an abovementioned instrument. We found it easy to apply and calculated a 
Cronbach’s alpha of 0.86 denoting it as a reliable instrument [Cardenas-Ibarra et al  2011b 
and 2011c]. NEUROPSI was used to describe the cognitive function of the elderly in a rural 
open population study. These results are being submitted for publication. Our team is 
committed to a project with an open population to determine the local overt and subclinical 
hypothyroidism prevalence in urban elderly. To identify enough elderly subjects with SH, 
besides the population section, additionally a convenient sample of elderly visiting hospital 
patients with unknown thyroidal status were invited to be tested. Subjects with known 
thyroidal problems were excluded, subjects with known dementia, arrhythmia, kidney, 
lung, heart severe dysfunction or cancer were also excluded. Thus, subjects identified as 
having subclinical hypothyroidism were invited to a clinical trial [Cárdenas-Ibarra et al 
2008b] with parallel control random assignment to test thyroxine versus placebo; which has 
not ended yet. Meanwhile, with the baseline data comparison was made between 37 subjects 
with SH and 39 controls (normal thyroid function) who were age and schooling matched. 
Impaired cognition in subjects with SH was almost double of that found in controls, in who 
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the prevalence of impaired cognition was as expected. These results have only been 
discussed in a congress [Cárdenas-Ibarra et al 2011d] 
A lower global cognitive status has been reported in hypothyroidism, specifically: attention, 
memory, word fluency, and psychomotor and visuospatial processes. Mixed results are 
reported for specific domains even in those with positive association. Moreover, 
improvement of cognitive impairement after levothyroxine replacement in elderly with SH 
has been reproted. Bono et al [Bono et al 2004] reported better verbal fluency after 6 moths 
with levothyroxine treatment. Enhanced elevating memory was reported by Monzani et al 
[Monzani et al 1993]. Enhanced working memory was noted after six months of thyroxine 
supplementation [Zhu et al 2006]. Improved response to antidepressants with levothyroxine 
has been documented in subjects with SH [Hage&Azar 2011] 
Data on the extent of dysfunction reversibility for cognitive processes is lacking. Much work 
needs to be done to standardize cognitive results for comparison and uniform protocols to get 
homogenous groups on thyroidal function (including and excluding criteria). Long survival 
without cognitive enjoyment of being is pointless. The goal now is quality of life. Since the 
cognitive processes are central to well-being, its preservation is as important as a healthy body.  
Cognitive labeling must be avoided; nevertheless timely repeated cognitive evaluation must 
be pursued to detect early decline and risks. Along with protocols to overcome 
cardiovascular risk and other preventable health problems, cognitive assessment by trained 
personnel to apply a neuropsychologically validated, reliable, and culturally compatible 
instrument must be performed. Interpretation and recommendations should be made by 
neuropsychologist or gerontologist consultants.  
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